Real-world outcomes among people receiving bictegravir/emtricitabine/tenofovir alafenamide: A comparison between those with and without advanced HIV-1 disease

Journal of Infection and Public Health · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles